Elite Health Systems Inc. Files 8-K

TL;DR

Elite Health Systems Inc. signed a big deal, filing an 8-K on Nov 29.

AI Summary

Elite Health Systems Inc. announced on November 29, 2024, that it entered into a material definitive agreement. The company, formerly known as U.S. NeuroSurgical Holdings, Inc., also reported other events. The filing was made on December 2, 2024.

Why It Matters

This 8-K filing indicates a significant event for Elite Health Systems Inc., potentially involving a new contract or business development that could impact its operations and financial standing.

Risk Assessment

Risk Level: medium — 8-K filings often signal material changes, but without details on the agreement, the specific risks are unknown.

Key Players & Entities

• Elite Health Systems Inc. (company) — Registrant
• U.S. NeuroSurgical Holdings, Inc. (company) — Former company name
• November 29, 2024 (date) — Date of earliest event reported
• December 2, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.50 — he Company's common stock at a price of $0.50 per share. To date, the Company has rai
• $5.05 million — as raised an aggregate of approximately $5.05 million. Effective November 29, 2024, the Board
• $5,500,000 m — of the private placement to raise up to $5,500,000 maximum. Item 8.01. Other Events Effec

Filing Documents

• usnu20241202_8k.htm (8-K) — 20KB
• 0001437749-24-036471.txt ( ) — 137KB
• usnu-20241129.xsd (EX-101.SCH) — 3KB
• usnu-20241129_def.xml (EX-101.DEF) — 10KB
• usnu-20241129_lab.xml (EX-101.LAB) — 14KB
• usnu-20241129_pre.xml (EX-101.PRE) — 10KB
• usnu20241202_8k_htm.xml (XML) — 2KB

01. Entry onto a Material Agreement

Item 1.01. Entry onto a Material Agreement. As previously reported, on January 16, 2024, Elite Health Systems Inc, formerly U.S. NeuroSurgical Holdings, Inc., a Delaware corporation, ("Company") held an initial closing of a private placement of shares of the Company's common stock at a price of $0.50 per share. To date, the Company has raised an aggregate of approximately $5.05 million. Effective November 29, 2024, the Board of Directors of the Company (the "Board") approved amending the terms of the private placement to raise up to $5,500,000 maximum.

01. Other Events

Item 8.01. Other Events Effective November 29, 2024, the Board approved the issuance of an aggregate of 480,000 shares of its Common Stock to certain individuals, including directors and officers of the Company, in lieu of cash compensation for services rendered and to be rendered through the 2024 fiscal year. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 2, 2024 Elite Health Systems Inc. By: /s/ Prasad Jeereddi Name: Prasad Jeereddi Title: Chairman and CEO 3

View Full Filing

View this 8-K filing on SEC EDGAR